SCHEMBL9837208

SCHEMBL9837208

CC(C)n1cncc1C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.65
TDP1 Q9NUW8 1/20 0.65
MAPK1 P28482 1/20 0.45
GABRA1 P14867 7/20 0.43
GABRB2 P47870 6/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
LMNA P02545 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ABCB11 O95342 1/20 0.43
GABRA2 P47869 1/20 0.43
HCAR3 P49019 2/20 0.39
GPBAR1 Q8TDU6 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 1/20 0.38
HCAR2 Q8TDS4 1/20 0.35
CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27981450 0.86 ALDH1A1 (0.49) ALDH1A1TDP1MAPK1GABRA1GABRB2
SCHEMBL25135971 0.82 ALDH1A1 (0.46) ALDH1A1TDP1MAPK1GABRA1GABRB2
SCHEMBL11726722 0.79 ALDH1A1 (1.00) ALDH1A1TDP1MAPK1GABRA1GABRB2
Hydrochloric Acid SCHEMBL1081962 0.78 ALDH1A1 (0.97) ALDH1A1TDP1MAPK1GABRA1GABRB2
SCHEMBL17693020 0.76 ALDH1A1 (0.71) ALDH1A1TDP1MAPK1GABRA1GABRB2
SCHEMBL22370231 0.76 ALDH1A1 (0.76) ALDH1A1TDP1MAPK1GABRA1GABRB2
SCHEMBL22370234 0.76 ALDH1A1 (0.76) ALDH1A1TDP1MAPK1GABRA1GABRB2
SCHEMBL16950285 0.76 ALDH1A1 (0.76) ALDH1A1TDP1MAPK1GABRA1GABRB2
Sulfuric Acid SCHEMBL11737786 0.74 ALDH1A1 (0.89) ALDH1A1TDP1MAPK1GABRA1GABRB2
SCHEMBL7340516 0.74 ALDH1A1 (0.71) ALDH1A1TDP1MAPK1GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353817-A1 INTERLUKIN-17A INHIBITORS AND USES THEREOF GILEAD SCIENCES INC (US) 2025-11-20 US disclosed
EP-4408530-A1 BENZIMIDAZOLES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2024-08-07 EP disclosed
CN-115884810-A Imidazopyridazines as IL-17 modulators 詹森药业有限公司 2023-03-31 CN disclosed
WO-2023049888-A1 BENZIMIDAZOLES AS MODULATORS OF IL-17 JANSSEN PHARMACEUTICA NV (BE) 2023-03-30 WO disclosed
EP-4143195-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2023-03-08 EP disclosed
EP-0191514-B1 IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS FUNGICIDES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-04-03 EP disclosed
EP-0191514-A1 Imidazole derivatives, their preparation and their use as fungicides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1986-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353817-A1 INTERLUKIN-17A INHIBITORS AND USES THEREOF IL17A, IL15, IL23R ALDH1A1 536/4885TDP1 3198/4885MAPK1 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.